NEW YORK, NY / ACCESSWIRE / August 2, 2022 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Apyx Medical Corporation (NASDAQ:APYX)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/apyx-medical-corporation-loss-submission-form-2?prid=30470&wire=1
Lead Plaintiff Deadline: August 5, 2022
Class Period: May 12, 2021 - March 11, 2022
Allegations against APYX include that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Energy Transfer LP (NYSE:ET)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/energy-transfer-lp-loss-submission-form-2?prid=30470&wire=1
Lead Plaintiff Deadline: August 2, 2022
This lawsuit is on behalf of persons who purchased or otherwise acquired common shares of Energy Transfer stock between April 13, 2017 and December 20, 2021, both dates inclusive.
Allegations against ET include that: (a) Energy Transfer had inadequate internal controls and procedures to prevent contractors from engaging in illegal conduct with regards to drilling activities, and/or failed to properly mitigate known issues related to such controls and procedures; (b) Energy Transfer, through its subsidiary Rover Pipeline, LLC, hired a third-party contractor to conduct Horizontal Directional Drilling Activities for the Rover Pipeline Project, whose conduct of adding illegal additives in the drilling mud caused severe pollution near the Tuscarawas River when a large inadvertent release took place on April 13, 2017; (c) Energy Transfer continually downplayed its potential civil liabilities when the Federal Energy Regulatory Commission ('FERC') was actively investigating the Energy Transfer's wrongdoing related to the April 13 release and consistently provided it with updated information about FERC's findings on this matter.
Verrica Pharmaceuticals, Inc. (NASDAQ:VRCA)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/verrica-pharmaceuticals-inc-loss-submission-form?prid=30470&wire=1
Lead Plaintiff Deadline: August 5, 2022
Class Period: May 28, 2021 - May 24, 2022
Allegations against VRCA include that: (1) there were manufacturing deficiencies at the facility where Verrica's contract manufacturer produced a bulk solution for the Company's lead product candidate, VP-102; (2) these deficiencies were not remediated when Verrica resubmitted its New Drug Application for VP-12 for molluscum; (3) the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email firstname.lastname@example.org or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE : The Law Offices of Vincent Wong
View source version on accesswire.com: